TickerFacts.

A business in context

TSHA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-344610

  2. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-344594 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-07-10 · 0001665124-26-000013

  4. 8-K · Current report

    Report date 2026-06-24 · 0001193125-26-282855 · Items 1.01,8.01,9.01

  5. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-276738 · Items 7.01,8.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-01 · 0001891712-26-000002

  7. 4 · Ownership change

    Report date 2026-06-01 · 0001777421-26-000005

  8. 4 · Ownership change

    Report date 2026-06-01 · 0001709418-26-000002

  9. 4 · Ownership change

    Report date 2026-06-01 · 0001238120-26-000008

  10. 8-K · Current report

    Report date 2026-06-01 · 0001193125-26-253478 · Items 5.07

  11. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-207666

  12. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-207633 · Items 2.02,9.01

  13. DEF 14A · Proxy statement

    Report date 2026-06-01 · 0001193125-26-168525

  14. 4 · Ownership change

    Report date 2026-04-10 · 0001665124-26-000011

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-115202

  16. 8-K · Current report

    Report date 2026-03-19 · 0001193125-26-115177 · Items 2.02,9.01

  17. 4 · Ownership change

    Report date 2026-02-04 · 0001793412-26-000012

  18. 4 · Ownership change

    Report date 2026-01-23 · 0001793412-26-000008

  19. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-263543 · Items 1.01,2.02,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-263506

  21. 8-K · Current report

    Report date 2025-10-16 · 0001193125-25-241415 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-10-09 · 0001193125-25-235212 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-10-02 · 0001193125-25-227505 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-08-12 · 0001193125-25-178504 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107010

  26. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-133745 · Items 5.03,5.07,9.01

  27. 8-K · Current report

    Report date 2025-05-28 · 0001193125-25-130709 · Items 1.01,8.01,9.01

  28. 8-K/A · Current report

    Report date 2025-05-28 · 0001193125-25-129849 · Items 7.01,8.01,9.01

  29. 8-K · Current report

    Report date 2025-05-28 · 0001193125-25-129494 · Items 7.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-05-15 · 0001193125-25-120329 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-072036

  32. DEF 14A · Proxy statement

    Report date 2025-06-02 · 0001193125-25-087214

  33. 8-K · Current report

    Report date 2025-02-26 · 0001193125-25-035882 · Items 2.02,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-027348

  35. SC 13G/A · Ownership disclosure

    0001104659-24-119336

  36. SC 13G/A · Ownership disclosure

    0001104659-24-119297

  37. SC 13G · Ownership disclosure

    0000902664-24-006533

  38. 8-K · Current report

    Report date 2024-11-13 · 0001193125-24-257205 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-126416

  40. SC 13G/A · Ownership disclosure

    0000315066-24-002879

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-10
2026-07-10
Nagendran Sukumar
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock200000.06.24

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001806310Taysha Gene Therapies, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$8.33M$8.95M
    2023-12-31$15.45M$17.08M
    2022-12-31$2.50M$2.88M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗